{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T03:02:16Z","timestamp":1787454136455,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"vor","delay-in-days":1050,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007114","name":"Ralph W. and Grace M. Showalter Research Trust Fund","doi-asserted-by":"publisher","award":["208453"],"award-info":[{"award-number":["208453"]}],"id":[{"id":"10.13039\/100007114","id-type":"DOI","asserted-by":"publisher"}]},{"name":"McKinley Trust","award":["770520401"],"award-info":[{"award-number":["770520401"]}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1074\/jbc.m117.800839","type":"journal-article","created":{"date-parts":[[2017,9,16]],"date-time":"2017-09-16T00:25:27Z","timestamp":1505521527000},"page":"18443-18456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Loss of cardiac carnitine palmitoyltransferase 2 results in rapamycin-resistant, acetylation-independent hypertrophy"],"prefix":"10.1016","volume":"292","author":[{"given":"Andrea S.","family":"Pereyra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Like Y.","family":"Hasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate L.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alycia G.","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick W.","family":"Damen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8883-7953","authenticated-orcid":false,"given":"Craig J.","family":"Goergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3803-8461","authenticated-orcid":false,"given":"Jessica M.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M117.800839_bib1","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/HJH.0000000000000607","article-title":"Aortic calcification is associated with arterial stiffening, left ventricular hypertrophy, and diastolic dysfunction in elderly male patients with hypertension","volume":"33","author":"Cho","year":"2015","journal-title":"J. Hypertens"},{"key":"10.1074\/jbc.M117.800839_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11906-015-0608-3","article-title":"The role of obesity in the development of left ventricular hypertrophy among children and adolescents","volume":"18","author":"Brady","year":"2016","journal-title":"Curr. Hypertens. Rep"},{"key":"10.1074\/jbc.M117.800839_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40292-014-0068-x","article-title":"Left ventricular hypertrophy and obesity: only a matter of fat?","volume":"22","author":"Murdolo","year":"2015","journal-title":"High Blood Press. Cardiovasc. Prev"},{"key":"10.1074\/jbc.M117.800839_bib4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2337\/db15-0627","article-title":"Relationship between left ventricular structural and metabolic remodeling in type 2 diabetes","volume":"65","author":"Levelt","year":"2016","journal-title":"Diabetes"},{"key":"10.1074\/jbc.M117.800839_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1440-1681.2007.04585.x","article-title":"Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treate heart failure","volume":"34","author":"McMullen","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol"},{"key":"10.1074\/jbc.M117.800839_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-108-1-7","article-title":"Echocardiographically detected left ventricular hypertrophy: revalence and risk factors: the Framingham Heart Study","volume":"108","author":"Levy","year":"1988","journal-title":"Ann. Intern. Med"},{"key":"10.1074\/jbc.M117.800839_bib7","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.ijcard.2014.07.251","article-title":"Left ventricular hypertrophy and QTc dispersion are predictors of long-term mortality in subjects with type 2 diabetes","volume":"176","author":"Bianco","year":"2014","journal-title":"Int. J. Cardiol"},{"key":"10.1074\/jbc.M117.800839_bib8","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0140-6736(02)08358-7","article-title":"Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths","volume":"359","author":"Struthers","year":"2002","journal-title":"Lancet"},{"key":"10.1074\/jbc.M117.800839_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-110-2-101","article-title":"Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study","volume":"110","author":"Levy","year":"1989","journal-title":"Ann. Intern. Med"},{"key":"10.1074\/jbc.M117.800839_bib10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0002-9629(15)40499-9","article-title":"Why is left ventricular hypertrophy so predictive of morbidity and mortality?","volume":"317","author":"Benjamin","year":"1999","journal-title":"Am. J. Med. Sci"},{"key":"10.1074\/jbc.M117.800839_bib11","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1067\/mhj.2000.111112","article-title":"Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension","volume":"140","author":"Brown","year":"2000","journal-title":"Am. Heart J"},{"key":"10.1074\/jbc.M117.800839_bib12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.18632\/aging.100881","article-title":"Rapamycin transiently induces mitochondrial remodeling to reprogram energy metabolism in old hearts","volume":"8","author":"Chiao","year":"2016","journal-title":"Aging"},{"key":"10.1074\/jbc.M117.800839_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1042\/bse0520023","article-title":"Mitochondrial protein acetylation regulates metabolism","volume":"52","author":"Anderson","year":"2012","journal-title":"Essays Biochem"},{"key":"10.1074\/jbc.M117.800839_bib14","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1253\/circj.CJ-15-0742","article-title":"Mitochondrion as a target for heart failure therapy: role of protein lysine acetylation","volume":"79","author":"Lee","year":"2015","journal-title":"Circ. J"},{"key":"10.1074\/jbc.M117.800839_bib15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.yjmcc.2011.11.004","article-title":"The role of SIRT3 in mitochondrial homeostasis and cardiac adaptation to hypertrophy and aging","volume":"52","author":"Sack","year":"2012","journal-title":"J. Mol. Cell Cardiol"},{"key":"10.1074\/jbc.M117.800839_bib16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.celrep.2014.12.023","article-title":"Adipose fatty acid oxidation is required for thermogenesis and potentiates oxidative stress-induced inflammation","volume":"10","author":"Lee","year":"2015","journal-title":"Cell Rep"},{"key":"10.1074\/jbc.M117.800839_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol. Rev"},{"key":"10.1074\/jbc.M117.800839_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-1536-5-15","article-title":"Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease","volume":"5","author":"Fan","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1074\/jbc.M117.800839_bib19","doi-asserted-by":"crossref","first-page":"D1251","DOI":"10.1093\/nar\/gkv1003","article-title":"MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins","volume":"44","author":"Calvo","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/jbc.M117.800839_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cell.2008.06.016","article-title":"A mitochondrial protein compendium elucidates complex I disease biology","volume":"134","author":"Pagliarini","year":"2008","journal-title":"Cell"},{"key":"10.1074\/jbc.M117.800839_bib21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/1756-0500-5-513","article-title":"A simple protocol for the subcellular fractionation of skeletal muscle cells and tissue","volume":"5","author":"Dimauro","year":"2012","journal-title":"BMC Res. Notes"},{"key":"10.1074\/jbc.M117.800839_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.celrep.2016.05.062","article-title":"Hepatic fatty acid oxidation restrains systemic catabolism during starvation","volume":"16","author":"Lee","year":"2016","journal-title":"Cell Rep"},{"key":"10.1074\/jbc.M117.800839_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/187152509787047603","article-title":"mTOR in growth and protection of hypertrophying myocardium","volume":"7","author":"Balasubramanian","year":"2009","journal-title":"Cardiovasc. Hematol. Agents Med. Chem"},{"key":"10.1074\/jbc.M117.800839_bib24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.pharmtox.47.120505.105359","article-title":"mTOR pathway as a target in tissue hypertrophy","volume":"47","author":"Lee","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol"},{"key":"10.1074\/jbc.M117.800839_bib25","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/jcp.21197","article-title":"Activation or inactivation of cardiac Akt\/mTOR signaling diverges physiological from pathological hypertrophy","volume":"214","author":"Kemi","year":"2008","journal-title":"J. Cell Physiol"},{"key":"10.1074\/jbc.M117.800839_bib26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCRESAHA.114.302022","article-title":"Mammalian target of rapamycin signaling in cardiac physiology and disease","volume":"114","author":"Sciarretta","year":"2014","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.M117.800839_bib27","doi-asserted-by":"crossref","first-page":"e001136","DOI":"10.1161\/JAHA.114.001136","article-title":"Cardiac energy dependence on glucose increases metabolites related to glutathione and activates metabolic genes controlled by mechanistic target of rapamycin","volume":"4","author":"Schisler","year":"2015","journal-title":"J. Am. Heart Assoc"},{"key":"10.1074\/jbc.M117.800839_bib28","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1073\/pnas.1015081108","article-title":"Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy","volume":"108","author":"Cao","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M117.800839_bib29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1080\/15592294.2015.1024406","article-title":"HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes","volume":"10","author":"Ooi","year":"2015","journal-title":"Epigenetics"},{"key":"10.1074\/jbc.M117.800839_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.105.559724","article-title":"Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding","volume":"113","author":"Kee","year":"2006","journal-title":"Circulation"},{"key":"10.1074\/jbc.M117.800839_bib31","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1172\/JCI19137","article-title":"Cardiac hypertrophy and histone deacetylase\u2013dependent transcriptional repression mediated by the atypical homeodomain protein Hop","volume":"112","author":"Kook","year":"2003","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.M117.800839_bib32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.diabres.2014.08.009","article-title":"\u03b2-Hydroxybutyrate: much more than a metabolite","volume":"106","author":"Newman","year":"2014","journal-title":"Diabetes Res. Clin. Pract"},{"key":"10.1074\/jbc.M117.800839_bib33","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/dom.12248","article-title":"Inhibition of carnitine palymitoyltransferase1b induces cardiac hypertrophy and mortality in mice","volume":"16","author":"Haynie","year":"2014","journal-title":"Diabetes Obes. Metab"},{"key":"10.1074\/jbc.M117.800839_bib34","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/labinvest.2009.86","article-title":"Cardiac hypertrophy in mice with long-chain acyl-CoA dehydrogenase or very long-chain acyl-CoA dehydrogenase deficiency","volume":"89","author":"Cox","year":"2009","journal-title":"Lab. Invest"},{"key":"10.1074\/jbc.M117.800839_bib35","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1128\/MCB.01085-10","article-title":"Mouse cardiac acyl coenzyme A synthetase 1 deficiency impairs fatty acid oxidation and induces cardiac hypertrophy","volume":"31","author":"Ellis","year":"2011","journal-title":"Mol. Cell Biol"},{"key":"10.1074\/jbc.M117.800839_bib36","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.bbadis.2013.07.023","article-title":"Regulation of fetal gene expression in heart failure","volume":"1832","author":"Dirkx","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M117.800839_bib37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1074\/jbc.M117.800839_bib38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10741-005-5249-1","article-title":"Thick filament proteins and performance in human heart failure","volume":"10","author":"Palmer","year":"2005","journal-title":"Heart Fail. Rev"},{"key":"10.1074\/jbc.M117.800839_bib39","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00059-002-2428-x","article-title":"The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure","volume":"27","author":"Rupp","year":"2002","journal-title":"Herz"},{"key":"10.1074\/jbc.M117.800839_bib40","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.bjp.0702312","article-title":"Modification of left ventricular hypertrophy by chronic etomoxir treatment","volume":"126","author":"Turcani","year":"1999","journal-title":"Br. J. Pharmacol"},{"key":"10.1074\/jbc.M117.800839_bib41","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1161\/01.CIR.96.10.3681","article-title":"Etomoxir improves left ventricular performance of pressure-overloaded rat heart","volume":"96","author":"Turcani","year":"1997","journal-title":"Circulation"},{"key":"10.1074\/jbc.M117.800839_bib42","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCRESAHA.114.301863","article-title":"Matrix revisited: mechanisms linking energy substrate metabolism to the function of the heart","volume":"114","author":"Carley","year":"2014","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.M117.800839_bib43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.tcm.2012.12.006","article-title":"HDAC-dependent ventricular remodeling","volume":"23","author":"Xie","year":"2013","journal-title":"Trends Cardiovasc. Med"},{"key":"10.1074\/jbc.M117.800839_bib44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijcard.2016.03.188","article-title":"HDAC inhibition: a novel therapeutic approach for attenuating heart failure by suppressing cardiac remodeling","volume":"214","author":"Wang","year":"2016","journal-title":"Int. J. Cardiol"},{"key":"10.1074\/jbc.M117.800839_bib45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cmet.2010.05.012","article-title":"Adipose acyl-CoA synthetase-1 (ACSL1) directs fatty acids towards \u03b2-oxidation and is required for cold thermogenesis","volume":"12","author":"Ellis","year":"2010","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.M117.800839_bib46","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bbalip.2014.03.001","article-title":"Deficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycin","volume":"1841","author":"Paul","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M117.800839_bib47","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1161\/HYPERTENSIONAHA.109.138818","article-title":"Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats","volume":"54","author":"Soesanto","year":"2009","journal-title":"Hypertension"},{"key":"10.1074\/jbc.M117.800839_bib48","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1210\/en.2007-0099","article-title":"Rapamycin prevents thyroid hormone-induced cardiac hypertrophy","volume":"148","author":"Kuzman","year":"2007","journal-title":"Endocrinology"},{"key":"10.1074\/jbc.M117.800839_bib49","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1161\/01.CIR.0000130641.08705.45","article-title":"Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload","volume":"109","author":"McMullen","year":"2004","journal-title":"Circulation"},{"key":"10.1074\/jbc.M117.800839_bib50","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/acel.12203","article-title":"Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart","volume":"13","author":"Dai","year":"2014","journal-title":"Aging Cell"},{"key":"10.1074\/jbc.M117.800839_bib51","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fphys.2016.00104","article-title":"Rapamycin inhibits cardiac hypertrophy by promoting autophagy via the MEK\/ERK\/Beclin-1 pathway","volume":"7","author":"Gu","year":"2016","journal-title":"Front. Physiol"},{"key":"10.1074\/jbc.M117.800839_bib52","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.bbrc.2006.06.006","article-title":"Crystal structure of rat carnitine palmitoyltransferase II (CPT-II)","volume":"346","author":"Hsiao","year":"2006","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.M117.800839_bib53","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/msb.2008.55","article-title":"InnateDB: facilitating systems-level analyses of the mammalian innate immune response","volume":"4","author":"Lynn","year":"2008","journal-title":"Mol. Syst. Biol"},{"key":"10.1074\/jbc.M117.800839_bib54","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M117.800839_bib55","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820329653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820329653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M117.800839","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T05:21:32Z","timestamp":1641273692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820329653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":55,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0021925820329653"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m117.800839","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of cardiac carnitine palmitoyltransferase 2 results in rapamycin-resistant, acetylation-independent hypertrophy","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M117.800839","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}